Viewing Study NCT05007132


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-01-10 @ 2:43 PM
Study NCT ID: NCT05007132
Status: RECRUITING
Last Update Posted: 2024-02-15
First Post: 2021-08-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Sponsor: Dominik Paul Modest
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic Colorectal Cancer View